MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-30
DOI
10.1186/s12935-020-01185-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors
- (2019) Johannes Ettl Breast Care
- To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response
- (2019) Qi Liu et al. DNA REPAIR
- p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
- (2019) Kanjoormana Manu et al. Cancers
- The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
- (2019) Al Bitar et al. Cancers
- The Emerging Role of Major Regulatory RNAs in Cancer Control
- (2019) Xiaofeng Dai et al. Frontiers in Oncology
- The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
- (2019) Roberta Roncarati et al. Frontiers in Oncology
- MiR-539 inhibited the malignant behaviors of breast cancer cells by targeting SP1
- (2019) Fenglin Cai et al. Biochemistry and Cell Biology
- Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)
- (2019) Concepción Sánchez-Martínez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- MiR-21 Promotes the Invasion and Metastasis of Gastric Cancer Cells by Activating Epithelial-Mesenchymal Transition
- (2019) Tao Xiao et al. EUROPEAN SURGICAL RESEARCH
- MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
- (2019) Maryam Abolghasemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
- (2019) Ling Wei et al. Molecular Cancer
- Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges
- (2019) Zeenat Mirza et al. SEMINARS IN CANCER BIOLOGY
- Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review
- (2019) Ashika D. Maharaj et al. HPB
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature
- (2019) Yan Chen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis
- (2018) Xin Zhou et al. GENE
- Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
- (2018) Frauke G. Heinemann et al. Clinical Epigenetics
- miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma
- (2018) Yufeng Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA
- (2018) Zhuo Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line
- (2018) Ruan CA Pimenta et al. TUMOR BIOLOGY
- CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression
- (2018) Ying Xu et al. Cancer Medicine
- Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy
- (2018) Ahmad Al-Shihabi et al. Molecular Therapy-Oncolytics
- Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma
- (2017) Ji Ma et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression
- (2016) Jing Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer
- (2014) Sercan Ergün et al. MOLECULAR BIOLOGY REPORTS
- The expression of cyclin G in nasopharyngeal carcinoma and its significance
- (2011) Xing-Xing Ye et al. CLINICAL AND EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now